Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	28.56	-105.93	-148.27
Graham Fair Price	0.00	3.28	3.28
PEG	0.00	0.00	0.00
Price/Book	-29.82	5.17	7.37
Price/Cash Flow	29.82	-85.14	-121.31
Prices/Earnings	29.82	-10.52	-14.99
Price/Sales	-29.82	20.83	29.68
Price/FCF	29.82	-85.14	-121.31
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.70	0.70
Operating Margin	0.00	-0.35	-0.35
ROA	0.00	-0.04	-0.04
ROE	-0.12	-0.12	0.00
ROIC	-0.05	-0.05	1.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.05	0.10	-50.92
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.13	0.00	inf
EPS QOQ	0.00	0.00	0.00
FCF QOQ	0.11	0.00	inf
Revenue QOQ	0.19	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	15.43	138.94	800.69
Days Sales Outstanding (DSO)	65.70	65.70	0.00
Inventory Turnover	5.83	0.65	-88.90
Debt/Capitalization	0.40	0.41	3.01
Quick Ratio	0.98	0.95	-3.07
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.97	1.97	0.00
Cash	1.07	1.02	-4.10
Capex	-0.05	-0.05	0.00
Free Cash Flow	-0.12	-0.12	0.00
Revenue	0.49	0.49	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.25	1.25	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.52	-3.64	-44.38
Naive Interpretation	Member

06 - Financial Health · Weak

Rating